\BOOKMARK [0][-]{chapter.1}{Transcription}{}% 1
\BOOKMARK [1][-]{section.1.1}{Recap on transcription}{chapter.1}% 2
\BOOKMARK [1][-]{section.1.2}{2- Transcriptional Control in Cancer}{chapter.1}% 3
\BOOKMARK [2][-]{subsection.1.2.1}{Transcription initiation}{section.1.2}% 4
\BOOKMARK [2][-]{subsection.1.2.2}{Chromatin remodeling}{section.1.2}% 5
\BOOKMARK [2][-]{subsection.1.2.3}{Nucleosome organization}{section.1.2}% 6
\BOOKMARK [1][-]{section.1.3}{3 \(1\)}{chapter.1}% 7
\BOOKMARK [2][-]{subsection.1.3.1}{Main nucleosome modifications in promoters:}{section.1.3}% 8
\BOOKMARK [1][-]{section.1.4}{4 - TCiC \(1\)}{chapter.1}% 9
\BOOKMARK [2][-]{subsection.1.4.1}{Structural basis of the nucleosome transition during RNA pol II passage - Kujirai et al 2018}{section.1.4}% 10
\BOOKMARK [1][-]{section.1.5}{Termination}{chapter.1}% 11
\BOOKMARK [0][-]{chapter.2}{Enhancer regulation}{}% 12
\BOOKMARK [1][-]{section.2.1}{5 - TCiC \(1\)}{chapter.2}% 13
\BOOKMARK [2][-]{subsection.2.1.1}{Wnt signalling pathway}{section.2.1}% 14
\BOOKMARK [1][-]{section.2.2}{6- Transcriptional Control in Cancer}{chapter.2}% 15
\BOOKMARK [1][-]{section.2.3}{CREP/p300}{chapter.2}% 16
\BOOKMARK [2][-]{subsection.2.3.1}{TSSa-RNAs transcription}{section.2.3}% 17
\BOOKMARK [0][-]{chapter.3}{CTCF}{}% 18
\BOOKMARK [1][-]{section.3.1}{7- Transcriptional Control in Cancer}{chapter.3}% 19
\BOOKMARK [0][-]{chapter.4}{TCIC}{}% 20
\BOOKMARK [1][-]{section.4.1}{13- Transcriptional Control in Cancer}{chapter.4}% 21
\BOOKMARK [1][-]{section.4.2}{Targeting transcription in cancer}{chapter.4}% 22
\BOOKMARK [2][-]{subsection.4.2.1}{Target transcription in cancer}{section.4.2}% 23
\BOOKMARK [1][-]{section.4.3}{15- Transcriptional Control in Cancer}{chapter.4}% 24
\BOOKMARK [1][-]{section.4.4}{BRD4}{chapter.4}% 25
\BOOKMARK [1][-]{section.4.5}{YAP/TAZ}{chapter.4}% 26
\BOOKMARK [1][-]{section.4.6}{TEAD}{chapter.4}% 27
\BOOKMARK [2][-]{subsection.4.6.1}{YAP/TAZ/TEAD}{section.4.6}% 28
\BOOKMARK [1][-]{section.4.7}{17- Transcriptional Control in Cancer}{chapter.4}% 29
\BOOKMARK [1][-]{section.4.8}{Nuclear receptors}{chapter.4}% 30
\BOOKMARK [2][-]{subsection.4.8.1}{Estrogen receptor \134alpha}{section.4.8}% 31
\BOOKMARK [2][-]{subsection.4.8.2}{ER\) in breast cancer}{section.4.8}% 32
\BOOKMARK [0][-]{chapter.5}{Genome instability}{}% 33
\BOOKMARK [1][-]{section.5.1}{19- Transcriptional Control in Cancer}{chapter.5}% 34
\BOOKMARK [1][-]{section.5.2}{Transcription and genome instability}{chapter.5}% 35
\BOOKMARK [2][-]{subsection.5.2.1}{R-loops}{section.5.2}% 36
\BOOKMARK [2][-]{subsection.5.2.2}{HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia}{section.5.2}% 37
\BOOKMARK [2][-]{subsection.5.2.3}{HOTTIP lncRNA Promotes Hematopoietic Stem Cells Self-Renewal Leading to AML-like Disease in Mice}{section.5.2}% 38
\BOOKMARK [1][-]{section.5.3}{20- Transcriptional Control in Cancer}{chapter.5}% 39
\BOOKMARK [1][-]{section.5.4}{Transcription and genome instability II}{chapter.5}% 40
\BOOKMARK [2][-]{subsection.5.4.1}{DNA damage}{section.5.4}% 41
\BOOKMARK [2][-]{subsection.5.4.2}{Apical kinases}{section.5.4}% 42
\BOOKMARK [2][-]{subsection.5.4.3}{Topoisomerases}{section.5.4}% 43
